Pfizer Korea, Korean drugmakers to face off in Lipitor war

Published: 2008-03-10 06:57:00

Updated: 2008-03-10 06:57:00

Now that Pfizer's Lipitor market thought to be still increasing, several Korean pharmaceutical firms are now focusing on the market with their generic products.

The run-ups include Hanmi Pharm, Yuhan Corporation, Dongwha Pharm, Chong Kung Dang Pharmaceuticals and Dong-A Pharm.

As Lipitor's ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK